Written by Dr. Lal PathLabs reported a robust financial performance for the first quarter of FY26, with net profit rising 24% year-on-year to ₹132 crore. The company’s revenue grew by 11.3%, reaching ₹670 crore, driven by higher diagnostic volumes and operational efficiency.
In addition to its strong earnings, the board of directors declared an interim dividend of ₹6 per share for FY26. The record date for the dividend has been set as August 6, 2025.
The solid performance and shareholder payout reflect the company’s continued focus on profitable growth and its confidence in maintaining momentum in the diagnostics sector.